Vespa crabro chromosome 8, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342407.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
calcium and integrin-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
bestrophin-4-like, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
bestrophin-4-like, transcript variant X2
bestrophin-4-like, transcript variant X1
RNA polymerase II-associated protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RNA polymerase II-associated protein 3 isoform X1
RNA polymerase II-associated protein 3 isoform X2
TRAF3-interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TRAF3-interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TRAF3-interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog
probable 26S proteasome non-ATPase regulatory subunit 3
homeotic protein empty spiracles-like, transcript variant X2
homeotic protein empty spiracles-like, transcript variant X3
homeotic protein empty spiracles-like, transcript variant X4
homeotic protein empty spiracles-like, transcript variant X5
homeotic protein empty spiracles-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124425902, transcript variant X2
uncharacterized LOC124425902, transcript variant X1
fumarylacetoacetate hydrolase domain-containing protein 2, transcript variant X2
fumarylacetoacetate hydrolase domain-containing protein 2, transcript variant X1
fumarylacetoacetate hydrolase domain-containing protein 2 isoform X2
fumarylacetoacetate hydrolase domain-containing protein 2 isoform X1
39S ribosomal protein L35, mitochondrial
lymphocyte antigen 6D, transcript variant X3
lymphocyte antigen 6D, transcript variant X4
lymphocyte antigen 6D, transcript variant X5
lymphocyte antigen 6D, transcript variant X7
lymphocyte antigen 6D, transcript variant X2
lymphocyte antigen 6D, transcript variant X1
lymphocyte antigen 6D, transcript variant X6
lymphocyte antigen 6D, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC124425866 isoform X2
ubiquitin-like domain-containing CTD phosphatase 1
phosphatidylinositide phosphatase SAC2, transcript variant X1
phosphatidylinositide phosphatase SAC2, transcript variant X2
phosphatidylinositide phosphatase SAC2 isoform X1
phosphatidylinositide phosphatase SAC2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
maternal protein exuperantia, transcript variant X2
maternal protein exuperantia, transcript variant X5
maternal protein exuperantia, transcript variant X3
maternal protein exuperantia, transcript variant X1
maternal protein exuperantia, transcript variant X6
maternal protein exuperantia, transcript variant X4
uncharacterized LOC124425883, transcript variant X2
uncharacterized LOC124425883, transcript variant X1
uncharacterized LOC124425883, transcript variant X3
ethanolamine-phosphate cytidylyltransferase, transcript variant X3
ethanolamine-phosphate cytidylyltransferase, transcript variant X4
ethanolamine-phosphate cytidylyltransferase, transcript variant X1
ethanolamine-phosphate cytidylyltransferase, transcript variant X2
ethanolamine-phosphate cytidylyltransferase isoform X1
ethanolamine-phosphate cytidylyltransferase isoform X2
ethanolamine-phosphate cytidylyltransferase isoform X3
probable ATP-dependent RNA helicase DDX5, transcript variant X1
probable ATP-dependent RNA helicase DDX5, transcript variant X2
ATP-dependent RNA helicase dbp2-like isoform X1
ATP-dependent RNA helicase dbp2-like isoform X2
probable ATP-dependent RNA helicase DDX5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX5 isoform X3
RNA-binding region-containing protein 3, transcript variant X1
RNA-binding region-containing protein 3, transcript variant X2
DNA ligase 1-like, transcript variant X2
DNA ligase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124425856, transcript variant X2
uncharacterized LOC124425856, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA-binding protein 8A, transcript variant X2
RNA-binding protein 8A, transcript variant X1
F-actin-monooxygenase Mical, transcript variant X3
F-actin-monooxygenase Mical, transcript variant X2
F-actin-monooxygenase Mical, transcript variant X1
F-actin-monooxygenase Mical, transcript variant X6
F-actin-monooxygenase Mical, transcript variant X7
F-actin-monooxygenase Mical, transcript variant X5
F-actin-monooxygenase Mical, transcript variant X4
protein-methionine sulfoxide oxidase mical3a isoform X3
F-actin-monooxygenase Mical, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ras-related protein Rab-21, transcript variant X2
ras-related protein Rab-21, transcript variant X1
rho GTPase-activating protein 1, transcript variant X2
rho GTPase-activating protein 1, transcript variant X1
rho GTPase-activating protein 1 isoform X1
rho GTPase-activating protein 1 isoform X2
cyclic GMP-AMP synthase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclic GMP-AMP synthase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cyclic GMP-AMP synthase-like, transcript variant X3
cyclic GMP-AMP synthase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclic GMP-AMP synthase-like, transcript variant X5
cyclic GMP-AMP synthase-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclic GMP-AMP synthase-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC124426266 isoform X3
uncharacterized protein LOC124426266 isoform X4
eukaryotic translation initiation factor 3 subunit J
bifunctional glutamate/proline--tRNA ligase
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X2
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X1
neuronal acetylcholine receptor subunit alpha-7-like isoform X1
neuronal acetylcholine receptor subunit alpha-7-like isoform X2
acetylcholine receptor subunit beta-like 1, transcript variant X2
acetylcholine receptor subunit beta-like 1, transcript variant X1
acetylcholine receptor subunit beta-like 1 isoform X1
acetylcholine receptor subunit beta-like 1 isoform X2
furin-like protease 1, transcript variant X4
furin-like protease 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
furin-like protease 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
furin-like protease 1, transcript variant X5
furin-like protease 1, transcript variant X1
furin-like protease 1, transcript variant X6
furin-like protease 1, isoforms 1/1-X/2 isoform X2
furin-like protease 1, isoforms 1/1-X/2 isoform X4
dynein axonemal intermediate chain 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
dynein intermediate chain 3, ciliary-like
cyclic AMP response element-binding protein A-like
DNA primase small subunit, transcript variant X1
DNA primase small subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase RING1, transcript variant X2
E3 ubiquitin-protein ligase RING1, transcript variant X1
E3 ubiquitin-protein ligase RING1 isoform X2
E3 ubiquitin-protein ligase RING1 isoform X1
uncharacterized LOC124426090, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124426090, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124426090, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC124426090 isoform X1
uncharacterized protein LOC124426090 isoform X2
uncharacterized protein LOC124426090 isoform X5
uncharacterized LOC124426090, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC124426090 isoform X3
uncharacterized LOC124426090, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC124426090 isoform X4
sodium-independent sulfate anion transporter-like, transcript variant X1
sodium-independent sulfate anion transporter-like, transcript variant X2
sodium-independent sulfate anion transporter-like, transcript variant X3
sodium-independent sulfate anion transporter-like isoform X1
sodium-independent sulfate anion transporter-like isoform X2
uncharacterized protein MAL13P1.304-like, transcript variant X1
uncharacterized protein MAL13P1.304-like isoform X1
uncharacterized protein MAL13P1.304-like, transcript variant X3
uncharacterized protein MAL13P1.304-like, transcript variant X2
uncharacterized protein MAL13P1.304-like, transcript variant X4
uncharacterized protein MAL13P1.304-like isoform X2
sodium-independent sulfate anion transporter-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X1
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X1
hepatocyte growth factor-regulated tyrosine kinase substrate, transcript variant X2
hepatocyte growth factor-regulated tyrosine kinase substrate isoform X2
protein CLEC16A homolog, transcript variant X4
protein CLEC16A homolog, transcript variant X2
protein CLEC16A homolog, transcript variant X3
protein CLEC16A homolog, transcript variant X1
protein CLEC16A homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124426244, transcript variant X3
uncharacterized LOC124426244, transcript variant X7
uncharacterized LOC124426244, transcript variant X8
tRNA (cytosine(38)-C(5))-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transcription factor MafG, transcript variant X2
transcription factor MafG, transcript variant X1
uncharacterized LOC124426244, transcript variant X4
uncharacterized protein LOC124426244 isoform X2
uncharacterized protein LOC124426244 isoform X4
uncharacterized protein LOC124426244 isoform X5
uncharacterized LOC124426244, transcript variant X6
uncharacterized protein LOC124426244 isoform X3
uncharacterized LOC124426244, transcript variant X1
uncharacterized LOC124426244, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124426244, transcript variant X2
uncharacterized protein LOC124426244 isoform X1
uncharacterized LOC124426120, transcript variant X2
uncharacterized LOC124426120, transcript variant X1
prominin-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
prominin-like protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
prominin-like protein, transcript variant X1
prominin-like protein, transcript variant X6
prominin-like protein, transcript variant X5
prominin-like protein, transcript variant X2
prominin-like protein, transcript variant X4
uncharacterized LOC124425910, transcript variant X2
uncharacterized LOC124425910, transcript variant X1
intraflagellar transport protein 56, transcript variant X2
intraflagellar transport protein 56, transcript variant X1
intraflagellar transport protein 56 isoform X2
intraflagellar transport protein 56 isoform X1
cytosolic Fe-S cluster assembly factor NUBP2 homolog
uridine 5'-monophosphate synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uridine 5'-monophosphate synthase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uridine 5'-monophosphate synthase, transcript variant X1
uridine 5'-monophosphate synthase isoform X2
uridine 5'-monophosphate synthase isoform X1
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X1
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X2
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X1
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X2
helicase POLQ-like, transcript variant X4
helicase POLQ-like, transcript variant X2
helicase POLQ-like, transcript variant X1
helicase POLQ-like, transcript variant X7
helicase POLQ-like, transcript variant X3
helicase POLQ-like, transcript variant X6
helicase POLQ-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase SETMAR-like
protein O-mannosyl-transferase TMTC1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1-like isoform X1
protein O-mannosyl-transferase TMTC1-like, transcript variant X3
protein O-mannosyl-transferase TMTC1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1-like isoform X2
protein O-mannosyl-transferase TMTC1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X8
ankyrin repeat and SAM domain-containing protein 1A-like isoform X6
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X10
ankyrin repeat and SAM domain-containing protein 1A-like isoform X7
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X9
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X3
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X5
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X4
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X2
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X6
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X1
ankyrin repeat and SAM domain-containing protein 1A-like isoform X5
ankyrin repeat and SAM domain-containing protein 1A-like isoform X4
uncharacterized protein LOC124425943 isoform X3
uncharacterized protein LOC124425943 isoform X2
uncharacterized protein LOC124425943 isoform X1
transmembrane 7 superfamily member 3-like
paired box protein Pax-6-like, transcript variant X4
paired box protein Pax-6-like, transcript variant X2
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like, transcript variant X3
paired box protein Pax-6-like isoform X1
paired box protein Pax-6-like isoform X2
paired box protein Pax-6-like isoform X4
paired box protein Pax-6-like isoform X3
torso-like protein, transcript variant X1
torso-like protein, transcript variant X4
torso-like protein, transcript variant X3
torso-like protein, transcript variant X5
torso-like protein, transcript variant X2
torso-like protein, transcript variant X7
torso-like protein, transcript variant X6
torso-like protein, transcript variant X8
torso-like protein, transcript variant X9
tetratricopeptide repeat protein 5-like, transcript variant X1
tetratricopeptide repeat protein 5-like, transcript variant X2
uncharacterized LOC124426084, transcript variant X1
uncharacterized LOC124426084, transcript variant X2
uncharacterized LOC124426083, transcript variant X1
uncharacterized LOC124426083, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC124426083 isoform X1
uncharacterized protein LOC124426083 isoform X2
DNA-directed RNA polymerase I subunit RPA12
venom dipeptidyl peptidase 4, transcript variant X1
venom dipeptidyl peptidase 4, transcript variant X5
venom dipeptidyl peptidase 4, transcript variant X10
venom dipeptidyl peptidase 4, transcript variant X2
venom dipeptidyl peptidase 4, transcript variant X3
venom dipeptidyl peptidase 4, transcript variant X4
venom dipeptidyl peptidase 4, transcript variant X7
venom dipeptidyl peptidase 4, transcript variant X9
venom dipeptidyl peptidase 4, transcript variant X8
venom dipeptidyl peptidase 4, transcript variant X6
transcription termination factor, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12, transcript variant X2
putative ATP-dependent RNA helicase TDRD12, transcript variant X1
putative ATP-dependent RNA helicase TDRD12 isoform X1
putative ATP-dependent RNA helicase TDRD12 isoform X2
putative ATP-dependent RNA helicase TDRD12 isoform X3
protein transport protein Sec23A, transcript variant X1
protein transport protein Sec23A, transcript variant X2
protein transport protein Sec23A isoform X2
protein transport protein Sec23A isoform X1
signal recognition particle subunit SRP68
serine protease inhibitor 28Dc, transcript variant X1
serine protease inhibitor 28Dc, transcript variant X2
serine protease inhibitor 28Dc isoform X1
serine protease inhibitor 28Dc isoform X2
intraflagellar transport protein 81 homolog, transcript variant X2
intraflagellar transport protein 81 homolog, transcript variant X1
intraflagellar transport protein 81 homolog isoform X2
intraflagellar transport protein 81 homolog isoform X1
uncharacterized LOC124426369, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124426369, transcript variant X2
glyoxylate reductase/hydroxypyruvate reductase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
phosphatidate phosphatase LPIN2, transcript variant X2
phosphatidate phosphatase LPIN2, transcript variant X5
phosphatidate phosphatase LPIN2, transcript variant X4
phosphatidate phosphatase LPIN2, transcript variant X3
phosphatidate phosphatase LPIN2, transcript variant X1
phosphatidate phosphatase LPIN2 isoform X1
phosphatidate phosphatase LPIN2 isoform X2
phosphatidate phosphatase LPIN2 isoform X5
phosphatidate phosphatase LPIN2 isoform X4
phosphatidate phosphatase LPIN2 isoform X3
14-3-3 protein zeta, transcript variant X5
14-3-3 protein zeta, transcript variant X4
14-3-3 protein zeta, transcript variant X1
14-3-3 protein zeta, transcript variant X2
14-3-3 protein zeta, transcript variant X6
14-3-3 protein zeta, transcript variant X7
14-3-3 protein zeta, transcript variant X3
ATP-dependent 6-phosphofructokinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ATP-dependent 6-phosphofructokinase, transcript variant X1
ATP-dependent 6-phosphofructokinase, transcript variant X3
ATP-dependent 6-phosphofructokinase, transcript variant X4
ATP-dependent 6-phosphofructokinase, transcript variant X2
ATP-dependent 6-phosphofructokinase, transcript variant X5
ATP-dependent 6-phosphofructokinase isoform X1
ATP-dependent 6-phosphofructokinase isoform X3
ATP-dependent 6-phosphofructokinase isoform X2
ATP-dependent 6-phosphofructokinase isoform X4
ATP-dependent 6-phosphofructokinase isoform X5
5-hydroxytryptamine receptor 2A, transcript variant X5
5-hydroxytryptamine receptor 2A, transcript variant X3
5-hydroxytryptamine receptor 2A, transcript variant X4
5-hydroxytryptamine receptor 2A, transcript variant X6
5-hydroxytryptamine receptor 2A, transcript variant X2
5-hydroxytryptamine receptor 2A, transcript variant X1
5-hydroxytryptamine receptor 2C isoform X4
5-hydroxytryptamine receptor 2A isoform X2
5-hydroxytryptamine receptor 2A isoform X1
5-hydroxytryptamine receptor 2A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ras-related protein Rab6, transcript variant X1
ras-related protein Rab6, transcript variant X2
ras-related protein Rab6, transcript variant X3
neuroligin-4, Y-linked, transcript variant X1
neuroligin-4, Y-linked, transcript variant X2
uncharacterized LOC124426029, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124426029, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124426029 isoform X1
uncharacterized protein LOC124426029 isoform X2
uncharacterized LOC124426029, transcript variant X3
uncharacterized protein LOC124426029 isoform X3
neuroligin-4, X-linked, transcript variant X2
neuroligin-4, X-linked, transcript variant X4
neuroligin-4, X-linked, transcript variant X3
neuroligin-4, X-linked, transcript variant X1
neuroligin-4, X-linked, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable serine/threonine-protein kinase yakA, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable serine/threonine-protein kinase yakA, transcript variant X1
probable serine/threonine-protein kinase yakA isoform X2
probable serine/threonine-protein kinase yakA isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like, transcript variant X2
protein arginine N-methyltransferase 9-like, transcript variant X1
protein arginine N-methyltransferase 9-like, transcript variant X6
protein arginine N-methyltransferase 9-like, transcript variant X7
protein arginine N-methyltransferase 9-like, transcript variant X5
protein arginine N-methyltransferase 9-like isoform X2
protein arginine N-methyltransferase 9-like isoform X1
protein arginine N-methyltransferase 9-like isoform X3
protein arginine N-methyltransferase 9-like isoform X4
protein arginine N-methyltransferase 9-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like isoform X5
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial
dynein light chain 2, cytoplasmic, transcript variant X2
dynein light chain 2, cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
methyltransferase-like protein 17, mitochondrial, transcript variant X3
methyltransferase-like protein 17, mitochondrial, transcript variant X2
methyltransferase-like protein 17, mitochondrial, transcript variant X1
methyltransferase-like protein 17, mitochondrial
GON-4-like protein, transcript variant X1
GON-4-like protein, transcript variant X2
GON-4-like protein, transcript variant X3
phosphorylated adapter RNA export protein, transcript variant X2
phosphorylated adapter RNA export protein, transcript variant X1
phosphorylated adapter RNA export protein
exosome complex exonuclease RRP42-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
exosome complex exonuclease RRP42-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X2
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X1
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X1
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X2
uncharacterized LOC124425986, transcript variant X3
uncharacterized LOC124425986, transcript variant X2
uncharacterized LOC124425986, transcript variant X1
uncharacterized protein LOC124425986 isoform X3
uncharacterized protein LOC124425986 isoform X2
uncharacterized protein LOC124425986 isoform X1
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
integrator complex subunit 11, transcript variant X2
integrator complex subunit 11, transcript variant X1
early endosome antigen 1-like, transcript variant X5
early endosome antigen 1-like, transcript variant X2
early endosome antigen 1-like, transcript variant X1
early endosome antigen 1-like, transcript variant X4
early endosome antigen 1-like, transcript variant X3
early endosome antigen 1-like, transcript variant X6
early endosome antigen 1-like, transcript variant X7
early endosome antigen 1-like isoform X4
vesicle transport protein USE1, transcript variant X1
vesicle transport protein USE1 isoform X1
vesicle transport protein USE1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vesicle transport protein USE1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
gamma-tubulin complex component 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gamma-tubulin complex component 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
gamma-tubulin complex component 4 isoform X2
gamma-tubulin complex component 4 isoform X1
GATA zinc finger domain-containing protein 10-like, transcript variant X2
GATA zinc finger domain-containing protein 10-like, transcript variant X3
GATA zinc finger domain-containing protein 10-like, transcript variant X1
GATA zinc finger domain-containing protein 10-like isoform X2
GATA zinc finger domain-containing protein 10-like isoform X3
GATA zinc finger domain-containing protein 10-like isoform X1
uncharacterized LOC124426290, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124426290, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124426290, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
anaphase-promoting complex subunit cdh1-like, transcript variant X3
anaphase-promoting complex subunit cdh1-like, transcript variant X4
anaphase-promoting complex subunit cdh1-like, transcript variant X5
anaphase-promoting complex subunit cdh1-like, transcript variant X1
anaphase-promoting complex subunit cdh1-like, transcript variant X2
anaphase-promoting complex subunit cdh1-like
anaphase-promoting complex subunit cdh1-like, transcript variant X6
uncharacterized LOC124426293, transcript variant X2
uncharacterized LOC124426293, transcript variant X1
zinc finger and SCAN domain-containing protein 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
enolase-phosphatase E1, transcript variant X3
enolase-phosphatase E1, transcript variant X2
enolase-phosphatase E1, transcript variant X1
uncharacterized LOC124426302, transcript variant X1
uncharacterized LOC124426302, transcript variant X2
zinc finger protein 615-like, transcript variant X3
zinc finger protein 615-like, transcript variant X1
zinc finger protein 615-like, transcript variant X2
cytochrome c oxidase subunit 5A, mitochondrial
DNA-binding protein P3A2, transcript variant X3
DNA-binding protein P3A2, transcript variant X4
DNA-binding protein P3A2, transcript variant X5
DNA-binding protein P3A2, transcript variant X1
DNA-binding protein P3A2, transcript variant X2
DNA-binding protein P3A2, transcript variant X6
5-demethoxyubiquinone hydroxylase, mitochondrial
scm-like with four MBT domains protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
scm-like with four MBT domains protein 1, transcript variant X3
scm-like with four MBT domains protein 1, transcript variant X4
scm-like with four MBT domains protein 1, transcript variant X2
scm-like with four MBT domains protein 1, transcript variant X1
scm-like with four MBT domains protein 1 isoform X2
scm-like with four MBT domains protein 2 isoform X3
scm-like with four MBT domains protein 1 isoform X1
peptide chain release factor 1-like, mitochondrial, transcript variant X2
peptide chain release factor 1-like, mitochondrial, transcript variant X1
peptide chain release factor 1-like, mitochondrial isoform X1
peptide chain release factor 1-like, mitochondrial isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X5
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X6
protein rolling stone-like, transcript variant X1
protein rolling stone-like, transcript variant X3
protein rolling stone-like, transcript variant X2
uncharacterized LOC124425964, transcript variant X2
uncharacterized LOC124425964, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
short stature homeobox protein 2-like, transcript variant X2
short stature homeobox protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
F-box/WD repeat-containing protein 9-like
solute carrier family 52, riboflavin transporter, member 3-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
outer dynein arm-docking complex subunit 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
outer dynein arm-docking complex subunit 4-like, transcript variant X1
uncharacterized LOC124426068, transcript variant X1
uncharacterized LOC124426068, transcript variant X3
uncharacterized LOC124426068, transcript variant X2
outer dynein arm-docking complex subunit 4-like isoform X2
outer dynein arm-docking complex subunit 4-like isoform X1
outer dynein arm-docking complex subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
bromodomain-containing protein 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
bromodomain-containing protein 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
bromodomain-containing protein 7, transcript variant X8
bromodomain-containing protein 7, transcript variant X7
bromodomain-containing protein 7, transcript variant X3
bromodomain-containing protein 7, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
bromodomain-containing protein 7, transcript variant X6
bromodomain-containing protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
bromodomain-containing protein 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
bromodomain-containing protein 7 isoform X1
bromodomain-containing protein 7 isoform X2
solute carrier family 12 member 4, transcript variant X4
solute carrier family 12 member 4, transcript variant X3
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 4, transcript variant X8
solute carrier family 12 member 6 isoform X5
solute carrier family 12 member 4, transcript variant X5
solute carrier family 12 member 4, transcript variant X7
solute carrier family 12 member 4, transcript variant X6
solute carrier family 12 member 6 isoform X4
NGFI-A-binding protein homolog, transcript variant X4
NGFI-A-binding protein homolog, transcript variant X2
NGFI-A-binding protein homolog, transcript variant X3
NGFI-A-binding protein homolog, transcript variant X1
NGFI-A-binding protein homolog isoform X4
NGFI-A-binding protein homolog isoform X2
NGFI-A-binding protein homolog isoform X3
NGFI-A-binding protein homolog isoform X1
NGFI-A-binding protein homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NGFI-A-binding protein homolog, transcript variant X5
dnaJ homolog subfamily C member 16, transcript variant X1
dnaJ homolog subfamily C member 16 isoform X1
dnaJ homolog subfamily C member 16, transcript variant X2
dnaJ homolog subfamily C member 16 isoform X2
uncharacterized LOC124426078, transcript variant X1
uncharacterized LOC124426078, transcript variant X2
ribonuclease P protein subunit p30, transcript variant X2
ribonuclease P protein subunit p30, transcript variant X1
aryl hydrocarbon receptor protein 1, transcript variant X1
aryl hydrocarbon receptor protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
aryl hydrocarbon receptor protein 1 isoform X3
aryl hydrocarbon receptor protein 1 isoform X1
aryl hydrocarbon receptor protein 1, transcript variant X3
aryl hydrocarbon receptor protein 1, transcript variant X2
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124425848, transcript variant X2
uncharacterized LOC124425848, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC124425848 isoform X1
uncharacterized protein LOC124425848 isoform X2
integrin alpha-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
integrin alpha-8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
integrin alpha-8-like, transcript variant X1
integrin alpha-8-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nucleoside-triphosphatase THEP1, transcript variant X2
nucleoside-triphosphatase THEP1, transcript variant X1
nucleoside-triphosphatase THEP1 isoform X1
nucleoside-triphosphatase THEP1 isoform X2
serine/threonine-protein phosphatase 5, transcript variant X2
serine/threonine-protein phosphatase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
corepressor interacting with RBPJ 1-like
keratin, type I cytoskeletal 9-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
keratin, type I cytoskeletal 9-like, transcript variant X1
keratin, type I cytoskeletal 9-like, transcript variant X2
sterol carrier protein 2, transcript variant X2
sterol carrier protein 2, transcript variant X1
dopamine receptor 1-like, transcript variant X1
dopamine receptor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
casein kinase II subunit alpha, transcript variant X6
protein PF14_0175-like, transcript variant X1
protein PF14_0175-like, transcript variant X2
protein PF14_0175-like, transcript variant X3
casein kinase II subunit alpha, transcript variant X2
casein kinase II subunit alpha, transcript variant X4
casein kinase II subunit alpha, transcript variant X3
casein kinase II subunit alpha, transcript variant X1
casein kinase II subunit alpha, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
casein kinase II subunit alpha isoform X2
casein kinase II subunit alpha isoform X1
translational activator of cytochrome c oxidase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
exosome complex component RRP45, transcript variant X1
exosome complex component RRP45, transcript variant X2
exosome complex component RRP45 isoform X1
exosome complex component RRP45 isoform X2
histone deacetylase complex subunit SAP30 homolog
MATH and LRR domain-containing protein PFE0570w-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
60S ribosomal protein L31, transcript variant X2
60S ribosomal protein L31, transcript variant X1
leucine-rich repeat protein 1, transcript variant X1
leucine-rich repeat protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
leucine-rich repeat protein 1 isoform X1
leucine-rich repeat protein 1 isoform X2
putative uncharacterized protein DDB_G0286901, transcript variant X1
putative uncharacterized protein DDB_G0286901, transcript variant X2
putative uncharacterized protein DDB_G0286901
ceramide glucosyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ceramide glucosyltransferase, transcript variant X2
ceramide glucosyltransferase, transcript variant X3
ceramide glucosyltransferase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ceramide glucosyltransferase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ceramide glucosyltransferase, transcript variant X5
ceramide glucosyltransferase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial, transcript variant X2
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial, transcript variant X1
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
muscarinic acetylcholine receptor DM1, transcript variant X2
muscarinic acetylcholine receptor DM1, transcript variant X1
muscarinic acetylcholine receptor DM1 isoform X2
muscarinic acetylcholine receptor DM1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
activator of 90 kDa heat shock protein ATPase homolog 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glutamate-gated chloride channel-like
probable cytochrome P450 6a17, transcript variant X2
probable cytochrome P450 6a17, transcript variant X1
cytochrome P450 6a2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 6a2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytochrome P450 6a2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
ejaculatory bulb-specific protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X4
aldehyde dehydrogenase, dimeric NADP-preferring isoform X4
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X3
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring isoform X3
aldehyde dehydrogenase, dimeric NADP-preferring isoform X2
aldehyde dehydrogenase, dimeric NADP-preferring isoform X1
aldehyde dehydrogenase, dimeric NADP-preferring isoform X5
aldehyde dehydrogenase, dimeric NADP-preferring isoform X6
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X8
putative glycerol kinase 5, transcript variant X2
putative glycerol kinase 5, transcript variant X1
nuclear transcription factor Y subunit beta-like
mRNA export factor GLE1-like, transcript variant X2
AF4/FMR2 family member lilli-like isoform X2
mRNA export factor GLE1-like, transcript variant X3
mRNA export factor GLE1-like, transcript variant X1
probable serine/threonine-protein kinase DDB_G0267686 isoform X1
mRNA export factor GLE1-like, transcript variant X4
AF4/FMR2 family member lilli-like isoform X4
mediator of RNA polymerase II transcription subunit 29, transcript variant X1
mediator of RNA polymerase II transcription subunit 29 isoform X1
mediator of RNA polymerase II transcription subunit 29, transcript variant X2
mediator of RNA polymerase II transcription subunit 29 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
electron transfer flavoprotein subunit beta
CDC42 small effector protein homolog, transcript variant X2
CDC42 small effector protein homolog, transcript variant X1
CDC42 small effector protein homolog, transcript variant X3
CDC42 small effector protein homolog, transcript variant X4
dnaJ homolog subfamily C member 7, transcript variant X1
dnaJ homolog subfamily C member 7, transcript variant X2
dnaJ homolog subfamily C member 7 isoform X1
dnaJ homolog subfamily C member 7 isoform X2
uncharacterized LOC124425875, transcript variant X1
uncharacterized LOC124425875, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC124425875 isoform X1
uncharacterized protein LOC124425875 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X3
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial isoform X3
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial isoform X2
trithorax group protein osa, transcript variant X3
trithorax group protein osa, transcript variant X2
trithorax group protein osa, transcript variant X1
trithorax group protein osa, transcript variant X7
trithorax group protein osa, transcript variant X6
trithorax group protein osa, transcript variant X4
trithorax group protein osa, transcript variant X5
vacuolar protein sorting-associated protein 13A-like, transcript variant X2
vacuolar protein sorting-associated protein 13A-like, transcript variant X1
vacuolar protein sorting-associated protein 13C-like isoform X2
vacuolar protein sorting-associated protein 13A-like isoform X1
uncharacterized LOC124426137, transcript variant X6
uncharacterized LOC124426137, transcript variant X2
uncharacterized LOC124426137, transcript variant X1
uncharacterized LOC124426137, transcript variant X7
uncharacterized LOC124426137, transcript variant X3
uncharacterized LOC124426137, transcript variant X4
uncharacterized LOC124426137, transcript variant X5
uncharacterized protein LOC124426137 isoform X3
uncharacterized protein LOC124426137 isoform X2
uncharacterized protein LOC124426137 isoform X1
iduronate 2-sulfatase, transcript variant X2
iduronate 2-sulfatase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X1
transcriptional regulator ATRX-like, transcript variant X2
transcriptional regulator ATRX-like, transcript variant X1
transcriptional regulator ATRX-like isoform X2
transcriptional regulator ATRX-like isoform X1
mediator of RNA polymerase II transcription subunit 4, transcript variant X1
mediator of RNA polymerase II transcription subunit 4, transcript variant X2
mediator of RNA polymerase II transcription subunit 4 isoform X2
mediator of RNA polymerase II transcription subunit 4 isoform X1
DNA replication complex GINS protein PSF1-like
uncharacterized LOC124425891, transcript variant X3
uncharacterized LOC124425891, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124425891, transcript variant X1
uncharacterized protein LOC124425891 isoform X2
uncharacterized protein LOC124425891 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
DBF4-type zinc finger-containing protein 2 homolog
ATPase family protein 2 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ATPase family protein 2 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ATPase family protein 2 homolog, transcript variant X3
bone morphogenetic protein 4-like, transcript variant X1
bone morphogenetic protein 4-like isoform X1
bone morphogenetic protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
bone morphogenetic protein 4-like isoform X2
intraflagellar transport protein 43 homolog, transcript variant X1
intraflagellar transport protein 43 homolog, transcript variant X2
intraflagellar transport protein 43 homolog isoform X1
intraflagellar transport protein 43 homolog isoform X2
mitochondrial import receptor subunit TOM40 homolog 1-like
endoplasmic reticulum lectin 1, transcript variant X2
endoplasmic reticulum lectin 1, transcript variant X1
endoplasmic reticulum lectin 1 isoform X2
endoplasmic reticulum lectin 1 isoform X1
protein CASC3-like, transcript variant X1
protein CASC3-like, transcript variant X2
orexin receptor type 2-like, transcript variant X5
orexin receptor type 2-like, transcript variant X1
orexin receptor type 2-like, transcript variant X3
orexin receptor type 2-like, transcript variant X2
orexin/Hypocretin receptor type 1-like isoform X3
orexin/Hypocretin receptor type 1-like isoform X1
orexin receptor type 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
orexin receptor type 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
orexin/Hypocretin receptor type 1-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
uncharacterized LOC124426040, transcript variant X2
protein croquemort, transcript variant X3
protein croquemort, transcript variant X4
protein croquemort, transcript variant X1
protein croquemort, transcript variant X2
intraflagellar transport protein 57 homolog
uncharacterized LOC124426040, transcript variant X1
uncharacterized protein LOC124426040 isoform X1
uncharacterized protein LOC124426040 isoform X2
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
mitochondrial intermediate peptidase, transcript variant X3
mitochondrial intermediate peptidase, transcript variant X1
mitochondrial intermediate peptidase, transcript variant X2
histone deacetylase 6, transcript variant X2
histone deacetylase 6, transcript variant X3
histone deacetylase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
proteasome assembly chaperone 1, transcript variant X2
proteasome assembly chaperone 1, transcript variant X1
proteasome assembly chaperone 1 isoform X2
proteasome assembly chaperone 1 isoform X1
delta(14)-sterol reductase LBR, transcript variant X2
delta(14)-sterol reductase LBR isoform X2
delta(14)-sterol reductase LBR, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
delta(14)-sterol reductase LBR isoform X1
heat shock factor 2-binding protein-like
monocarboxylate transporter 3, transcript variant X2
monocarboxylate transporter 3, transcript variant X5
monocarboxylate transporter 3, transcript variant X1
monocarboxylate transporter 3 isoform X1
monocarboxylate transporter 3 isoform X2
monocarboxylate transporter 12 isoform X5
monocarboxylate transporter 3, transcript variant X4
monocarboxylate transporter 3 isoform X4
monocarboxylate transporter 3, transcript variant X3
monocarboxylate transporter 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124426261, transcript variant X3
uncharacterized LOC124426261, transcript variant X1
uncharacterized LOC124426261, transcript variant X2
uncharacterized protein LOC124426261 isoform X1
uncharacterized protein LOC124426261 isoform X3
uncharacterized protein LOC124426261 isoform X2
lysM and putative peptidoglycan-binding domain-containing protein 3
uncharacterized LOC124426259, transcript variant X11
uncharacterized LOC124426259, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124426259, transcript variant X2
uncharacterized LOC124426259, transcript variant X5
uncharacterized LOC124426259, transcript variant X7
uncharacterized LOC124426259, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124426259, transcript variant X1
uncharacterized LOC124426259, transcript variant X15
uncharacterized LOC124426259, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124426259, transcript variant X3
uncharacterized LOC124426259, transcript variant X10
uncharacterized LOC124426259, transcript variant X8
uncharacterized LOC124426259, transcript variant X9
uncharacterized LOC124426259, transcript variant X13
uncharacterized LOC124426259, transcript variant X12
tyrosine-protein phosphatase non-receptor type 14, transcript variant X3
tyrosine-protein phosphatase non-receptor type 14, transcript variant X2
tyrosine-protein phosphatase non-receptor type 14, transcript variant X1
tyrosine-protein phosphatase non-receptor type 14 isoform X2
tyrosine-protein phosphatase non-receptor type 14 isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X5
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X1
scaffold protein salvador-like, transcript variant X4
scaffold protein salvador-like, transcript variant X7
scaffold protein salvador-like, transcript variant X1
scaffold protein salvador-like, transcript variant X2
scaffold protein salvador-like, transcript variant X3
scaffold protein salvador-like isoform X1
scaffold protein salvador-like isoform X2
protein salvador homolog 1-like isoform X3
scaffold protein salvador-like, transcript variant X6
scaffold protein salvador-like, transcript variant X5
scaffold protein salvador-like, transcript variant X8
scaffold protein salvador-like isoform X4
uncharacterized LOC124426168, transcript variant X1
uncharacterized LOC124426168, transcript variant X3
uncharacterized LOC124426168, transcript variant X2
nuclear inhibitor of protein phosphatase 1, transcript variant X2
nuclear inhibitor of protein phosphatase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear inhibitor of protein phosphatase 1, transcript variant X1
nuclear inhibitor of protein phosphatase 1 isoform X1
nuclear inhibitor of protein phosphatase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
thioredoxin, mitochondrial, transcript variant X1
thioredoxin, mitochondrial, transcript variant X4
lysophospholipase-like protein 1, transcript variant X1
lysophospholipase-like protein 1, transcript variant X2
lysophospholipase-like protein 1 isoform X1
lysophospholipase-like protein 1 isoform X2
thioredoxin, mitochondrial, transcript variant X5
thioredoxin, mitochondrial, transcript variant X3
thioredoxin, mitochondrial, transcript variant X2
pecanex-like protein 1, transcript variant X4
pecanex-like protein 1, transcript variant X2
pecanex-like protein 1, transcript variant X3
pecanex-like protein 1, transcript variant X1
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X1
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X3
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 11-like isoform X1
mitogen-activated protein kinase kinase kinase 11-like isoform X3
mitogen-activated protein kinase kinase kinase 11-like isoform X2
galactose mutarotase-like, transcript variant X5
galactose mutarotase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
galactose mutarotase-like, transcript variant X2
galactose mutarotase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
galactose mutarotase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ATP-dependent DNA helicase DDX11, transcript variant X2
ATP-dependent DNA helicase DDX11, transcript variant X1
eukaryotic translation initiation factor 3 subunit F
26S proteasome non-ATPase regulatory subunit 8
elongation factor 1-gamma, transcript variant X1
elongation factor 1-gamma, transcript variant X2
probable 39S ribosomal protein L49, mitochondrial
putative uncharacterized protein DDB_G0282133
uncharacterized LOC124426240, transcript variant X4
uncharacterized LOC124426240, transcript variant X1
uncharacterized LOC124426240, transcript variant X2
uncharacterized LOC124426240, transcript variant X3
glutaredoxin-related protein 5, mitochondrial, transcript variant X3
glutaredoxin-related protein 5, mitochondrial, transcript variant X1
glutaredoxin-related protein 5, mitochondrial, transcript variant X2
glutaredoxin-related protein 5, mitochondrial isoform X1
glutaredoxin-related protein 5, mitochondrial isoform X2
glutaredoxin-related protein 5, mitochondrial, transcript variant X4
glutaredoxin-related protein 5, mitochondrial isoform X3
4-coumarate-CoA ligase 1-like, transcript variant X1
4-coumarate-CoA ligase 1-like, transcript variant X2
4-coumarate-CoA ligase 1-like, transcript variant X3
4-coumarate-CoA ligase 1-like isoform X1
4-coumarate-CoA ligase 1-like isoform X2
cell wall integrity and stress response component 1-like
potassium voltage-gated channel protein eag, transcript variant X1
potassium voltage-gated channel protein eag, transcript variant X5
potassium voltage-gated channel protein eag, transcript variant X3
potassium voltage-gated channel protein eag, transcript variant X6
potassium voltage-gated channel protein eag, transcript variant X2
potassium voltage-gated channel protein eag, transcript variant X4
potassium voltage-gated channel protein eag, transcript variant X7
potassium voltage-gated channel protein eag isoform X1
potassium voltage-gated channel protein eag isoform X5
potassium voltage-gated channel protein eag isoform X3
potassium voltage-gated channel protein eag isoform X6
potassium voltage-gated channel protein eag isoform X2
potassium voltage-gated channel protein eag isoform X4
potassium voltage-gated channel protein eag isoform X7
MTOR-associated protein MEAK7, transcript variant X2
MTOR-associated protein MEAK7, transcript variant X3
MTOR-associated protein MEAK7, transcript variant X1
zinc finger protein 706-like, transcript variant X3
zinc finger protein 706-like, transcript variant X2
zinc finger protein 706-like, transcript variant X1
E3 ubiquitin-protein ligase hyd, transcript variant X1
E3 ubiquitin-protein ligase hyd, transcript variant X3
E3 ubiquitin-protein ligase hyd, transcript variant X2
E3 ubiquitin-protein ligase UBR5 isoform X1
E3 ubiquitin-protein ligase hyd isoform X3
E3 ubiquitin-protein ligase hyd isoform X2
protein bunched, class 2/F/G isoform-like, transcript variant X2
protein bunched, class 2/F/G isoform-like, transcript variant X1
protein bunched, class 2/F/G isoform-like
RCC1-like G exchanging factor-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124426395, transcript variant X1
uncharacterized LOC124426395, transcript variant X2
uncharacterized LOC124426395, transcript variant X3
uncharacterized protein LOC124426395 isoform X1
uncharacterized protein LOC124426395 isoform X2
uncharacterized protein LOC124426395 isoform X3
DENN domain-containing protein 1A, transcript variant X4
DENN domain-containing protein 1A, transcript variant X2
DENN domain-containing protein 1A, transcript variant X1
DENN domain-containing protein 1A, transcript variant X3
DENN domain-containing protein 1A, transcript variant X5
DENN domain-containing protein 1A isoform X4
DENN domain-containing protein 1A isoform X2
DENN domain-containing protein 1A isoform X5
DENN domain-containing protein 1A isoform X1
DENN domain-containing protein 1A isoform X3
serine/threonine-protein phosphatase 4 regulatory subunit 2-like, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 2-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 2-like
ATP-binding cassette sub-family B member 10, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transmembrane protein 184B, transcript variant X2
transmembrane protein 184B, transcript variant X1
transmembrane protein 184B, transcript variant X3
transmembrane protein 184B, transcript variant X6
transmembrane protein 184B, transcript variant X5
transmembrane protein 184B, transcript variant X4
RCC1 and BTB domain-containing protein 1-like, transcript variant X2
RCC1 and BTB domain-containing protein 1-like, transcript variant X1
RCC1 and BTB domain-containing protein 1-like isoform X1
RCC1 and BTB domain-containing protein 1-like isoform X2
acetylcholinesterase-like, transcript variant X4
acetylcholinesterase-like, transcript variant X2
acetylcholinesterase-like, transcript variant X1
acetylcholinesterase-like, transcript variant X5
acetylcholinesterase-like, transcript variant X3
interleukin-1 receptor accessory protein-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
interleukin-1 receptor accessory protein-like 1, transcript variant X1
interleukin-1 receptor accessory protein-like 1
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X1
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X2
probable multidrug resistance-associated protein lethal(2)03659 isoform X2
probable multidrug resistance-associated protein lethal(2)03659 isoform X1
wiskott-Aldrich syndrome protein family member 3, transcript variant X4
wiskott-Aldrich syndrome protein family member 3, transcript variant X8
wiskott-Aldrich syndrome protein family member 3, transcript variant X7
wiskott-Aldrich syndrome protein family member 3, transcript variant X6
wiskott-Aldrich syndrome protein family member 3, transcript variant X2
wiskott-Aldrich syndrome protein family member 3, transcript variant X5
wiskott-Aldrich syndrome protein family member 3, transcript variant X3
wiskott-Aldrich syndrome protein family member 3, transcript variant X1
wiskott-Aldrich syndrome protein family member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
wiskott-Aldrich syndrome protein family member 3 isoform X2
wiskott-Aldrich syndrome protein family member 3 isoform X1
mitochondrial 2-oxodicarboxylate carrier, transcript variant X3
mitochondrial 2-oxodicarboxylate carrier, transcript variant X5
mitochondrial 2-oxodicarboxylate carrier, transcript variant X1
mitochondrial 2-oxodicarboxylate carrier, transcript variant X4
mitochondrial 2-oxodicarboxylate carrier, transcript variant X2
mitochondrial 2-oxodicarboxylate carrier isoform X2
mitochondrial 2-oxodicarboxylate carrier isoform X1
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 5 isoform X1
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 5 isoform X2
structural maintenance of chromosomes protein 1A-like
origin recognition complex subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
origin recognition complex subunit 1, transcript variant X2
origin recognition complex subunit 1, transcript variant X3
glutamate-gated chloride channel, transcript variant X7
glutamate-gated chloride channel, transcript variant X6
glutamate-gated chloride channel, transcript variant X2
glutamate-gated chloride channel, transcript variant X3
glutamate-gated chloride channel, transcript variant X27
glutamate-gated chloride channel, transcript variant X5
glutamate-gated chloride channel, transcript variant X4
glutamate-gated chloride channel, transcript variant X11
glutamate-gated chloride channel, transcript variant X10
glutamate-gated chloride channel, transcript variant X1
glutamate-gated chloride channel, transcript variant X12
glutamate-gated chloride channel, transcript variant X9
glutamate-gated chloride channel, transcript variant X18
glutamate-gated chloride channel, transcript variant X17
glutamate-gated chloride channel, transcript variant X16
glutamate-gated chloride channel, transcript variant X15
glutamate-gated chloride channel, transcript variant X14
glutamate-gated chloride channel, transcript variant X13
glutamate-gated chloride channel, transcript variant X20
glutamate-gated chloride channel, transcript variant X19
glutamate-gated chloride channel, transcript variant X21
glutamate-gated chloride channel, transcript variant X24
glutamate-gated chloride channel, transcript variant X23
glutamate-gated chloride channel, transcript variant X22
glutamate-gated chloride channel, transcript variant X26
glutamate-gated chloride channel, transcript variant X25
glutamate-gated chloride channel, transcript variant X8
glutamate-gated chloride channel isoform X19
glutamate-gated chloride channel isoform X18
glutamate-gated chloride channel isoform X17
glutamate-gated chloride channel isoform X16
glutamate-gated chloride channel isoform X15
glutamate-gated chloride channel isoform X13
glutamate-gated chloride channel alpha isoform X14
glutamate-gated chloride channel isoform X20
glutamate-gated chloride channel isoform X5
glutamate-gated chloride channel isoform X2
glutamate-gated chloride channel isoform X12
glycine receptor subunit alpha-4 isoform X11
glycine receptor subunit alpha-4 isoform X10
glutamate-gated chloride channel isoform X9
glutamate-gated chloride channel isoform X8
glutamate-gated chloride channel isoform X7
glutamate-gated chloride channel isoform X6
glutamate-gated chloride channel isoform X4
glutamate-gated chloride channel isoform X3
glutamate-gated chloride channel isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 379 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
flavin-containing monooxygenase FMO GS-OX-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: flavin-containing monooxygenase FMO GS-OX-like 2
serine/threonine-protein kinase 10, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine/threonine-protein kinase 10, transcript variant X11
serine/threonine-protein kinase 10 isoform X6
serine/threonine-protein kinase 10 isoform X4
serine/threonine-protein kinase 10, transcript variant X2
serine/threonine-protein kinase 10, transcript variant X4
serine/threonine-protein kinase 10, transcript variant X7
serine/threonine-protein kinase 10, transcript variant X1
serine/threonine-protein kinase 10, transcript variant X8
serine/threonine-protein kinase 10, transcript variant X3
serine/threonine-protein kinase 10, transcript variant X6
serine/threonine-protein kinase 10, transcript variant X5
serine/threonine-protein kinase 10, transcript variant X10
serine/threonine-protein kinase 10 isoform X3
serine/threonine-protein kinase 10 isoform X2
serine/threonine-protein kinase 10 isoform X1
STE20-like serine/threonine-protein kinase isoform X5
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2
poly(U)-binding-splicing factor half pint, transcript variant X1
poly(U)-binding-splicing factor half pint, transcript variant X2
poly(U)-binding-splicing factor half pint, transcript variant X7
poly(U)-binding-splicing factor half pint, transcript variant X6
poly(U)-binding-splicing factor half pint, transcript variant X5
poly(U)-binding-splicing factor half pint, transcript variant X4
poly(U)-binding-splicing factor half pint, transcript variant X3
poly(U)-binding-splicing factor half pint, transcript variant X8
poly(U)-binding-splicing factor half pint isoform X1
poly(U)-binding-splicing factor half pint isoform X2
poly(U)-binding-splicing factor half pint isoform X3
poly(U)-binding-splicing factor half pint isoform X4
histone-lysine N-trimethyltransferase SMYD5, transcript variant X1
histone-lysine N-trimethyltransferase SMYD5, transcript variant X2
histone-lysine N-trimethyltransferase SMYD5 isoform X1
histone-lysine N-trimethyltransferase SMYD5 isoform X2
small nuclear ribonucleoprotein-associated protein B, transcript variant X1
small nuclear ribonucleoprotein-associated protein B, transcript variant X2
small nuclear ribonucleoprotein-associated protein B
BRCA2-interacting transcriptional repressor EMSY, transcript variant X2
BRCA2-interacting transcriptional repressor EMSY, transcript variant X1
BRCA2-interacting transcriptional repressor EMSY isoform X2
BRCA2-interacting transcriptional repressor EMSY isoform X1
BRCA2-interacting transcriptional repressor EMSY, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
BRCA2-interacting transcriptional repressor EMSY isoform X3
BRCA2-interacting transcriptional repressor EMSY, transcript variant X4
BRCA2-interacting transcriptional repressor EMSY isoform X4
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
plasma membrane ascorbate-dependent reductase CYBRD1, transcript variant X4
plasma membrane ascorbate-dependent reductase CYBRD1 isoform X1
plasma membrane ascorbate-dependent reductase CYBRD1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC124426316 isoform X1
uncharacterized protein LOC124426316 isoform X2
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X3
uncharacterized protein LOC124426316 isoform X4
DNA-directed RNA polymerase I subunit RPA43
breast cancer type 2 susceptibility protein homolog, transcript variant X1
breast cancer type 2 susceptibility protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
breast cancer type 2 susceptibility protein homolog isoform X1
breast cancer type 2 susceptibility protein-like isoform X2
breast cancer type 2 susceptibility protein homolog, transcript variant X3
breast cancer type 2 susceptibility protein homolog isoform X3
thyrotroph embryonic factor-like, transcript variant X2
thyrotroph embryonic factor-like, transcript variant X1
thyrotroph embryonic factor-like, transcript variant X4
thyrotroph embryonic factor-like, transcript variant X8
thyrotroph embryonic factor-like, transcript variant X3
thyrotroph embryonic factor-like, transcript variant X5
thyrotroph embryonic factor-like, transcript variant X6
thyrotroph embryonic factor-like, transcript variant X7
thyrotroph embryonic factor-like isoform X5
thyrotroph embryonic factor-like isoform X6
juvenile hormone epoxide hydrolase 1-like, transcript variant X1
juvenile hormone epoxide hydrolase 1-like, transcript variant X2
juvenile hormone epoxide hydrolase 1-like isoform X1
juvenile hormone epoxide hydrolase 1-like isoform X2
juvenile hormone epoxide hydrolase 1-like
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X3
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X3
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X2
nucleoside diphosphate kinase, transcript variant X2
nucleoside diphosphate kinase, transcript variant X1
cell death-inducing p53-target protein 1-like
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, transcript variant X1
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, transcript variant X4
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, transcript variant X3
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, transcript variant X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, transcript variant X5
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog
uncharacterized LOC124425929, transcript variant X1
uncharacterized LOC124425929, transcript variant X2
U6 snRNA-associated Sm-like protein LSm5
anion exchange protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
anion exchange protein 2, transcript variant X5
anion exchange protein 2, transcript variant X3
anion exchange protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
anion exchange protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
anion exchange protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
band 3 anion transport protein isoform X2
disco-interacting protein 2 homolog A, transcript variant X1
disco-interacting protein 2 homolog A isoform X1
disco-interacting protein 2 homolog A, transcript variant X5
disco-interacting protein 2 homolog A, transcript variant X3
disco-interacting protein 2 homolog A, transcript variant X2
disco-interacting protein 2 homolog A, transcript variant X4
disco-interacting protein 2 homolog A isoform X5
disco-interacting protein 2 homolog A isoform X3
disco-interacting protein 2 homolog A isoform X2
spermine synthase, transcript variant X1
spermine synthase, transcript variant X3
spermine synthase, transcript variant X2
storkhead-box protein 2, transcript variant X2
storkhead-box protein 2, transcript variant X1
storkhead-box protein 2, transcript variant X4
storkhead-box protein 2, transcript variant X3
CCR4-NOT transcription complex subunit 6-like, transcript variant X3
CCR4-NOT transcription complex subunit 6-like, transcript variant X2
CCR4-NOT transcription complex subunit 6-like, transcript variant X1
CCR4-NOT transcription complex subunit 6-like isoform X1
probable serine/threonine-protein kinase DDB_G0267686
CCR4-NOT transcription complex subunit 6-like, transcript variant X4
CCR4-NOT transcription complex subunit 6-like isoform X2
uncharacterized LOC124426332, transcript variant X2
uncharacterized LOC124426332, transcript variant X1
uncharacterized protein LOC124426332 isoform X2
uncharacterized protein LOC124426332 isoform X1
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
28S ribosomal protein S24, mitochondrial, transcript variant X2
28S ribosomal protein S24, mitochondrial, transcript variant X1
28S ribosomal protein S24, mitochondrial isoform X2
28S ribosomal protein S24, mitochondrial isoform X1
MKI67 FHA domain-interacting nucleolar phosphoprotein-like
thyrotropin-releasing hormone-degrading ectoenzyme-like, transcript variant X2
thyrotropin-releasing hormone-degrading ectoenzyme-like, transcript variant X1
thyrotropin-releasing hormone-degrading ectoenzyme-like isoform X1
thyrotropin-releasing hormone-degrading ectoenzyme-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
TWiK family of potassium channels protein 18-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
acetylcholine receptor subunit alpha-like, transcript variant X2
acetylcholine receptor subunit alpha-like, transcript variant X1
acetylcholine receptor subunit alpha-like, transcript variant X3
acetylcholine receptor subunit alpha-like, transcript variant X4
acetylcholine receptor subunit alpha-like isoform X1
acetylcholine receptor subunit alpha-like isoform X2
acetylcholine receptor subunit alpha-like, transcript variant X5
acetylcholine receptor subunit alpha-like isoform X3
aminopeptidase N-like, transcript variant X2
aminopeptidase N-like, transcript variant X1
twisted gastrulation protein homolog 1-A-like, transcript variant X3
twisted gastrulation protein homolog 1-A-like, transcript variant X2
twisted gastrulation protein homolog 1-A-like isoform X2
twisted gastrulation protein homolog 1-A-like, transcript variant X1
twisted gastrulation protein homolog 1-A-like isoform X1
twisted gastrulation protein homolog 1-A-like, transcript variant X4
twisted gastrulation protein homolog 1-A-like isoform X3
uncharacterized LOC124426210, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124426210, transcript variant X4
uncharacterized LOC124426210, transcript variant X3
uncharacterized LOC124426210, transcript variant X1
uncharacterized LOC124426210, transcript variant X5
uncharacterized protein LOC124426210 isoform X3
uncharacterized protein LOC124426210 isoform X1
uncharacterized protein LOC124426210 isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1
S-phase kinase-associated protein 2-like
S-phase kinase-associated protein 2-like, transcript variant X1
S-phase kinase-associated protein 2-like, transcript variant X2
S-phase kinase-associated protein 2-like isoform X1
S-phase kinase-associated protein 2-like isoform X2
S-phase kinase-associated protein 2-like, transcript variant X3
lysine-specific demethylase 2A-like isoform X3
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X1
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X3
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X2
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X1
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X3
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X2
uncharacterized LOC124426018, transcript variant X3
uncharacterized LOC124426018, transcript variant X2
uncharacterized LOC124426018, transcript variant X1
uncharacterized LOC124426018, transcript variant X5
uncharacterized LOC124426018, transcript variant X4
uncharacterized protein LOC124426018 isoform X2
uncharacterized protein LOC124426018 isoform X1
general transcription factor 3C polypeptide 2, transcript variant X1
general transcription factor 3C polypeptide 2, transcript variant X2
general transcription factor 3C polypeptide 2 isoform X1
uncharacterized protein LOC124426144 isoform X2
forkhead box protein N3-like, transcript variant X1
forkhead box protein N3-like, transcript variant X5
forkhead box protein N3-like, transcript variant X2
forkhead box protein N3-like, transcript variant X3
forkhead box protein N3-like, transcript variant X6
forkhead box protein N3-like, transcript variant X4
interference hedgehog-like, transcript variant X2
interference hedgehog-like, transcript variant X1
interference hedgehog-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
growth arrest-specific protein 2-like, transcript variant X2
growth arrest-specific protein 2-like, transcript variant X1
growth arrest-specific protein 2-like, transcript variant X3
growth arrest-specific protein 2-like isoform X2
growth arrest-specific protein 2-like isoform X3
growth arrest-specific protein 2-like isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X5
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X5
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X1
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X3
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X4
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X2
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X5
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X6
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X7
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X8
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X9
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X10
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X12
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X11
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X13
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X14
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X15
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X16
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X17
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X1
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X3
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X6
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X7
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X8
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X9
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X13
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X15
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X4
calcium/calmodulin-dependent protein kinase type II delta chain isoform X10
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X12
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X2
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X14
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X16
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X5
calcium/calmodulin-dependent protein kinase type II delta chain isoform X11
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X17
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DDB1- and CUL4-associated factor 6-like, transcript variant X3
DDB1- and CUL4-associated factor 6-like, transcript variant X2
DDB1- and CUL4-associated factor 6-like, transcript variant X1
DDB1- and CUL4-associated factor 6-like isoform X3
DDB1- and CUL4-associated factor 6-like isoform X2
DDB1- and CUL4-associated factor 6-like isoform X1
protein PRRC1-B-like, transcript variant X3
protein PRRC1-B-like, transcript variant X1
protein PRRC1-B-like, transcript variant X2
cyclin-dependent kinases regulatory subunit
excitatory amino acid transporter 1, transcript variant X7
excitatory amino acid transporter 1, transcript variant X1
excitatory amino acid transporter 1, transcript variant X4
excitatory amino acid transporter 1, transcript variant X3
excitatory amino acid transporter 1, transcript variant X6
excitatory amino acid transporter 1, transcript variant X2
excitatory amino acid transporter 1, transcript variant X5
excitatory amino acid transporter 1 isoform X1
excitatory amino acid transporter 1 isoform X2
vacuolar protein-sorting-associated protein 25
NEDD8-conjugating enzyme UBE2F-like, transcript variant X1
NEDD8-conjugating enzyme UBE2F-like, transcript variant X4
NEDD8-conjugating enzyme UBE2F-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
NEDD8-conjugating enzyme UBE2F-like, transcript variant X2
NEDD8-conjugating enzyme UBE2F-like isoform X1
NEDD8-conjugating enzyme UBE2F-like isoform X3
NEDD8-conjugating enzyme UBE2F-like isoform X2
glutamic acid-rich protein, transcript variant X3
glutamic acid-rich protein, transcript variant X7
glutamic acid-rich protein, transcript variant X6
glutamic acid-rich protein, transcript variant X5
glutamic acid-rich protein, transcript variant X4
glutamic acid-rich protein, transcript variant X1
glutamic acid-rich protein, transcript variant X2
glutamic acid-rich protein, transcript variant X14
glutamic acid-rich protein, transcript variant X13
glutamic acid-rich protein, transcript variant X11
glutamic acid-rich protein, transcript variant X10
glutamic acid-rich protein, transcript variant X9
glutamic acid-rich protein, transcript variant X12
glutamic acid-rich protein, transcript variant X8
uncharacterized protein LOC124425971 isoform X8
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X1
feline leukemia virus subgroup C receptor-related protein 2 isoform X1
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X2
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X3
feline leukemia virus subgroup C receptor-related protein 2 isoform X2
feline leukemia virus subgroup C receptor-related protein 2 isoform X3
tyrosine-protein kinase Btk29A, transcript variant X2
tyrosine-protein kinase Btk29A, transcript variant X1
tyrosine-protein kinase Btk29A, transcript variant X3
tyrosine-protein kinase Btk29A, transcript variant X5
tyrosine-protein kinase Btk29A, transcript variant X6
tyrosine-protein kinase Btk29A, transcript variant X8
tyrosine-protein kinase Btk29A, transcript variant X10
tyrosine-protein kinase Btk29A, transcript variant X7
tyrosine-protein kinase Btk29A, transcript variant X9
tyrosine-protein kinase Btk29A isoform X3
tyrosine-protein kinase Btk29A isoform X1
tyrosine-protein kinase Btk29A isoform X2
tyrosine-protein kinase Btk29A isoform X5
tyrosine-protein kinase Btk29A isoform X6
tyrosine-protein kinase Btk29A isoform X7
tyrosine-protein kinase Btk29A, transcript variant X4
tyrosine-protein kinase Btk29A isoform X4
mediator of RNA polymerase II transcription subunit 7, transcript variant X1
mediator of RNA polymerase II transcription subunit 7, transcript variant X2
mediator of RNA polymerase II transcription subunit 7
uncharacterized LOC124426199, transcript variant X2
uncharacterized LOC124426199, transcript variant X1
serine/arginine-rich splicing factor 2, transcript variant X1
serine/arginine-rich splicing factor 2, transcript variant X2
lysophospholipid acyltransferase 7, transcript variant X1
lysophospholipid acyltransferase 7, transcript variant X2
lysophospholipid acyltransferase 7, transcript variant X3
lysophospholipid acyltransferase 7 isoform X1
lysophospholipid acyltransferase 7 isoform X2
nuclear export mediator factor NEMF homolog, transcript variant X2
nuclear export mediator factor NEMF homolog, transcript variant X1
nuclear export mediator factor NEMF homolog isoform X1
nuclear export mediator factor NEMF homolog isoform X2
nuclear export mediator factor NEMF homolog, transcript variant X3
nuclear export mediator factor NEMF homolog isoform X3
serine/threonine-protein kinase VRK1-like
serine/threonine-protein kinase greatwall, transcript variant X2
serine/threonine-protein kinase greatwall, transcript variant X1
serine/threonine-protein kinase greatwall, transcript variant X3
serine/threonine-protein kinase greatwall
protein grainyhead, transcript variant X3
protein grainyhead, transcript variant X5
protein grainyhead, transcript variant X1
protein grainyhead, transcript variant X2
uncharacterized protein LOC124426275 isoform X3
protein grainyhead, transcript variant X4
regulator of G-protein signaling 19, transcript variant X6
regulator of G-protein signaling 19, transcript variant X5
regulator of G-protein signaling 19, transcript variant X3
regulator of G-protein signaling 19, transcript variant X2
regulator of G-protein signaling 19, transcript variant X1
regulator of G-protein signaling 19, transcript variant X4
regulator of G-protein signaling 17 isoform X1
regulator of G-protein signaling 17 isoform X2
regulator of G-protein signaling 19 isoform X3
uncharacterized LOC124425933, transcript variant X2
uncharacterized LOC124425933, transcript variant X1
uncharacterized LOC124425933, transcript variant X8
uncharacterized LOC124425933, transcript variant X4
uncharacterized LOC124425933, transcript variant X3
uncharacterized LOC124425933, transcript variant X5
uncharacterized LOC124425933, transcript variant X7
uncharacterized LOC124425933, transcript variant X6
uncharacterized protein LOC124425933 isoform X1
uncharacterized protein LOC124425933 isoform X2
DNA primase small subunit-like, transcript variant X6
DNA primase small subunit-like, transcript variant X7
DNA primase small subunit-like, transcript variant X3
DNA primase small subunit-like, transcript variant X4
DNA primase small subunit-like, transcript variant X5
DNA primase small subunit-like, transcript variant X2
DNA primase small subunit-like, transcript variant X1
DNA primase small subunit-like isoform X2
DNA primase small subunit-like isoform X3
DNA primase small subunit-like isoform X1
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X2
intraflagellar transport protein 74 homolog
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X3
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X2
Ca(2+)/calmodulin-responsive adenylate cyclase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
cyclin-dependent kinase 10, transcript variant X1
cyclin-dependent kinase 10, transcript variant X3
cyclin-dependent kinase 10, transcript variant X2
cyclin-dependent kinase 10, transcript variant X4
ejaculatory bulb-specific protein 3-like, transcript variant X2
ejaculatory bulb-specific protein 3-like, transcript variant X1
UBX domain-containing protein 7, transcript variant X2
UBX domain-containing protein 7, transcript variant X1
UBX domain-containing protein 7, transcript variant X3
UBX domain-containing protein 7 isoform X1
UBX domain-containing protein 7 isoform X2